Answers are grounded in this paper and cite their sources.
Case report demonstrates significant repigmentation following Unani medicated oil and narrowband UV-B phototherapy in an adult male, highlighting an effective integrative strategy for vitiligo...
Introduction: Vitiligo vulgaris is a chronic depigmenting disorder that poses therapeutic challenges and psychosocial distress. Conventional therapies often yield inconsistent outcomes, necessitating alternative or integrative approaches. Case Presentation: A 40-year-old male with multiple depigmented patches on the infraclavicular area, upper back, and lower back, with remarkable clinical improvement following combined therapy with Unani medicated oil and narrowband UV-B (NB-UVB) phototherapy. Outcome: After three months of treatment, significant and stable repigmentation was achieved without adverse effects. Conclusion: This case highlights the potential of integrating Unani topical medication with NB-UVB phototherapy as a safe and effective therapeutic strategy for vitiligo vulgaris unresponsive to prior treatments.
No takes yet. Share an insight, caveat, or question.
Afzal et al. (2026) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: